[Observing in HIV infections].
Vittecocq
D
D
D019380:Anti-HIV Agents / Q000008:administration & dosage / Q000627:therapeutic use; D016049:Didanosine / Q000008:administration & dosage / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D015658:HIV Infections / Q000628:therapy*; D006801:Humans; D010349:Patient Compliance; D010817:Physician-Patient Relations; D018894:Reverse Transcriptase Inhibitors / Q000008:administration & dosage; D013997:Time Factors; D015215:Zidovudine / Q000008:administration & dosage / Q000627:therapeutic use
D019380:Anti-HIV Agents; D018894:Reverse Transcriptase Inhibitors; D015215:Zidovudine; D016049:Didanosine
Observance dans l'infection à VIH.